SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), in an effort to further constantly develop Avant! which is held by GBT Tokenize LLC (“GBT ...
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it intends to offer $250.0 million aggregate principal amount of ...
GBT Realty has capitalized on two of its recent developments, selling apartment high-rises and a retail parcel to Elmington Residential for a combined $96.5 million. Elmington bought the 210-unit ...
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced it has entered into an agreement with Sanofi S.A. to exclusively ...
SOUTH SAN FRANCISCO, Calif., Dec. 06, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced new preclinical data on its sickle cell disease (SCD) pipeline ...
American Express Global Business Travel's newly announced acquisition of rival CWT would be a merger of giants but might not face the regulatory scrutiny that has quashed recent major mergers in the ...
GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease Positive results from Phase 1 study of GBT601, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results